Irinotecan Teva 20 mg / ml concentrate for solution for infusion
- Licence status
- Withdrawn: 08/05/2012
- Active substances
- Irinotecan hydrochloride trihydrate
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- PA0749/044/001
- Licence holder
- Teva Pharma B.V.
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01XX Other antineoplastic agents, L01XX19 irinotecan
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 14/03/2008